CHARLESTON, W.Va. (AP) — Federal prosecutors in West Virginia's southern district have announced a $4 million settlement with Rite Aid Corp. to resolve a criminal investigation of pseudoephedrine sales over a four-year period.
U.S. Attorney Mike Stuart says in a news release the drug store chain accepts responsibility for the improper sales, which occurred between January 2009 and October 2012.
The statement says the company's policies led employees in the district to believe they could only deny a pseudoephedrine sale if it would cause a customer to exceed a purchase limit amount, and not if the customer was suspected of wanting the drug for an illegitimate reason, such as the manufacture of methamphetamine.
The statement says Rite Aid has instituted changes in its training, policies and procedures for selling pseudoephedrine, including placing such products out of customer view.
Rite Aid reaches $4M settlement over pseudoephedrine sales
Jan 24, 2018 at 11:10 AM Jan 24, 2018 at 11:11 AM